Can combining different risk interventions into a single formulation contribute to improved cardiovascular disease risk reduction? Rationale and design for an international, open-label program to assess the effectiveness of a single pill (amlodipine/atorvastatin) to attain recommended target levels for blood pressure and lipids (The JEWEL Program)

Publication | Closed Access

DOI

Citations

References

2005

Year

Richard Hobbs, Gianfranco Gensini, G.B. John Mancini, Athanasios Manolis, Beverly Bauer, Steffen Böhler, Jacques Genest, Ross D. Feldman, Peter Harvey, Trond Jenssen,

International Journal of Cardiology

Non-pharmacological InterventionHypertensionJewel ProgramCardiovascular DiseaseMedicineAntihypertensive TherapyRiskOutcomes ResearchDifferent Risk InterventionsPharmacotherapySingle PillPharmacologic InterventionPublic HealthPharmacology